معرفی
Professor Michael Okorie serves as Professor of Clinical Pharmacology and Therapeutics and Head of the Department of Medical Education at Brighton and Sussex Medical School (BSMS), with concurrent roles as Honorary Consultant Physician and Associate Medical Director for Medicines Safety at University Hospitals Sussex. His academic leadership spans medical education innovation, hypertension research, and global antimicrobial stewardship initiatives.
His research expertise centers on three interconnected domains:
- Hypertension Pathophysiology – Investigating white-coat hypertension mechanisms through arterial stiffness biomarkers and clinical trials (e.g., HYVET 2 feasibility study)
- Antimicrobial Stewardship – Developing hub-and-spoke implementation models for resource-limited settings, particularly in Zambia
- Medical Education Innovation – Designing inclusive prescribing curricula for neurodiverse learners and integrating climate sustainability into clinical training
His scholarly impact is evidenced by 64+ publications (2022-2025) in high-impact journals including British Journal of Clinical Pharmacology and Journal of Hypertension, with notable works on race-conscious pharmacotherapy education and sustainable medicines development. Awards include Fellowship of the Royal College of Physicians (2016).
As an educator, he leads BSMS's medical education strategy while supervising doctoral projects focused on real-world healthcare challenges. His grants portfolio includes Tropical Health and Education Trust funding for Zambian antimicrobial programs and Dunhill Medical Trust support for elderly hypertension research. Current initiatives emphasize translating research into NHS policy through his medicines safety leadership role.
